Chemical, Structural, Clinical and Biological details of Antiviral agents ID: DrugRepV_5089



Chemical Information
Antiviral agent IDDrugRepV_5089
Antiviral agent nameS-Nitroso-N-acetylpenicillamine
IUPAC Name(2~{R})-2-acetamido-3-methyl-3-nitrososulfanylbutanoic acid PubChem
SMILES (canonical)CC(=O)NC(C(=O)O)C(C)(C)SN=O PubChem
SMILES (isomeric)CC(=O)N[C@H](C(=O)O)C(C)(C)SN=O PubChem
Molecular FormulaC7H12N2O4S PubChem
Molecular Weight (g/mol)220.243 PubChem
InChlInChI=1S/C7H12N2O4S/c1-4(10)8-5(6(11)12)7(2,3)14-9-13/h5H,1-3H3,(H,8,10)(H,11,12)/t5-/m1/s1 PubChem
SynonymsN-Acetyl-3-(nitrosothio)-valine | N-acetyl-3-(nitrosothio)-D-Valine | s-nitroso-l-acetyl penicillamine
Structural Information
  
Clinical Information
Biological Information
Secondary Indication Crimean-Congo hemorrhagic fever virus (CCHFV) NA IbAr 10200World Health OrganisationCDC
Secondary Indication (Approaches)Experimental
Secondary Indication (Methods)In-vitro
Secondary Indication (Model system) [cell lines/ animal models]VeroE6
Secondary Indication (Mode of viral infection)Adsorption
Secondary Indication (Viral titer)0.03 MOI
Secondary Indication (Mode of drug delivery) Culture
Secondary Indication (Time of drug delivery) Pre infection (3 or 6 hours)
Secondary Indication (Duration of drug delivery)24 hours
Secondary Indication (Drug concentration)400 μM
Secondary Indication (Cell based assay)Immunoflourescence assay
Secondary Indication (Change)Decrease
Secondary Indication (Type of Inhibition) Percentage inhibition [ >90 % ]
ReferenceSimon M, Falk KI, Lundkvist A, Mirazimi A..Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus..Virus Res. 2006 Sep;120(1-2):184-90. Epub 2006 May 2. PMID:16632039 PubMed
CommentThe expression of viral proteins; the nucleocapsid protein and the glycoprotein, were reduced with increasing concentrations of SNAP.